No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs2036462 |
chr1:47489786-47489787 |
Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
2 |
rs558253703 |
chr1:47489794-47489795 |
Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs557731759 |
chr1:47489795-47489796 |
Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs568738179 |
chr1:47489796-47489797 |
Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs529533653 |
chr1:47489838-47489839 |
Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Weak transcription Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs111783250 |
chr1:47489842-47489843 |
Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Weak transcription Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs112563041 |
chr1:47489915-47489916 |
Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Weak transcription Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs568407658 |
chr1:47489952-47489953 |
Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Weak transcription Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs183665344 |
chr1:47490078-47490079 |
Bivalent/Poised TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs145581426 |
chr1:47490080-47490081 |
Bivalent/Poised TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs116478445 |
chr1:47490144-47490145 |
Bivalent/Poised TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs558369430 |
chr1:47490230-47490231 |
Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs570144882 |
chr1:47490246-47490247 |
Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs186881357 |
chr1:47490255-47490256 |
Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs192217378 |
chr1:47490274-47490275 |
Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs11582076 |
chr1:47490291-47490292 |
Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs72890400 |
chr1:47490307-47490308 |
Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs183112870 |
chr1:47490386-47490387 |
Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs534172554 |
chr1:47490438-47490439 |
Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Weak transcription Active TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs187832302 |
chr1:47490442-47490443 |
Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Weak transcription Active TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs553928019 |
chr1:47490487-47490488 |
Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Weak transcription Active TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs76692053 |
chr1:47490572-47490573 |
Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Weak transcription Active TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs546307831 |
chr1:47490638-47490639 |
Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs564556034 |
chr1:47490724-47490725 |
Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs72890402 |
chr1:47490744-47490745 |
Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
26 |
rs543811427 |
chr1:47490793-47490794 |
Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs77025411 |
chr1:47490819-47490820 |
Bivalent Enhancer Enhancers Bivalent/Poised TSS Weak transcription Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs529553129 |
chr1:47490840-47490841 |
Bivalent Enhancer Enhancers Bivalent/Poised TSS Weak transcription Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs146786267 |
chr1:47490857-47490858 |
Bivalent Enhancer Enhancers Bivalent/Poised TSS Weak transcription Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs140462364 |
chr1:47490865-47490866 |
Bivalent Enhancer Enhancers Bivalent/Poised TSS Weak transcription Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs372631659 |
chr1:47490872-47490873 |
Bivalent Enhancer Enhancers Bivalent/Poised TSS Weak transcription Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs115955363 |
chr1:47490883-47490884 |
Bivalent Enhancer Enhancers Bivalent/Poised TSS Weak transcription Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs1553391 |
chr1:47490974-47490975 |
Bivalent Enhancer Enhancers Bivalent/Poised TSS Weak transcription Flanking Active TSS Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
34 |
rs372969677 |
chr1:47491103-47491104 |
Enhancers Bivalent Enhancer Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs143660444 |
chr1:47491170-47491171 |
Enhancers Bivalent Enhancer Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs555699105 |
chr1:47491184-47491185 |
Enhancers Bivalent Enhancer Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs576392246 |
chr1:47491229-47491230 |
Enhancers Bivalent Enhancer Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs55802147 |
chr1:47491255-47491256 |
Enhancers Bivalent Enhancer Weak transcription Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
39 |
rs148104296 |
chr1:47491262-47491263 |
Enhancers Bivalent Enhancer Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs553760854 |
chr1:47491317-47491318 |
Enhancers Bivalent Enhancer Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs60371503 |
chr1:47491358-47491359 |
Enhancers Bivalent Enhancer Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs9701154 |
chr1:47491360-47491361 |
Enhancers Bivalent Enhancer Weak transcription Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
43 |
rs182227389 |
chr1:47491383-47491384 |
Enhancers Bivalent Enhancer Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs576559748 |
chr1:47491393-47491394 |
Enhancers Bivalent Enhancer Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs543849182 |
chr1:47491394-47491395 |
Enhancers Bivalent Enhancer Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs188217309 |
chr1:47491546-47491547 |
Enhancers Bivalent Enhancer Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs150238868 |
chr1:47491572-47491573 |
Enhancers Bivalent Enhancer Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs139276459 |
chr1:47491579-47491580 |
Enhancers Bivalent Enhancer Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs143304532 |
chr1:47491609-47491610 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs559759510 |
chr1:47491611-47491612 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|